Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl)

被引:86
作者
Zeng, S
Xu, ZH
Lipkowitz, S
Longley, JB
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA
[3] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2004-05-1768
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activation of the KIT receptor tyrosine kinase contributes to the pathogenesis of several human diseases, but the mechanisms regulating KIT signaling have not been fully characterized. Here, we show that stem cell factor (SCF), the ligand for KIT, induces the interaction between KIT and Cbl proteins and their mutual degradation. Upon SCF stimulation, KIT binds to and induces the phosphorylation of Cbl proteins, which in turn act as E3 ligases, mediating the ubiquitination and degradation of KIT and themselves. Tyrosine kinase binding and RING finger domains of Cbl are essential for Cbl-mediated ubiquitination and degradation of KIT. We propose a negative feedback loop controlling the SCF-KIT signaling pathway, in which SCF activates KIT. The activated KIT in turn induces phosphorylation and activation of Cbl proteins. The Cbl proteins then bind and direct the degradation of activated KIT, leading to down-regulation of KIT signaling. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 30 条
[1]   Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b [J].
Bachmaier, K ;
Krawczyk, C ;
Kozieradzki, I ;
Kong, YY ;
Sasaki, T ;
Oliveira-dos-Santos, A ;
Mariathasan, S ;
Bouchard, D ;
Wakeham, A ;
Itie, A ;
Le, J ;
Ohashi, PS ;
Sarosi, I ;
Nishina, H ;
Lipkowitz, S ;
Penninger, JM .
NATURE, 2000, 403 (6766) :211-216
[2]  
BESMER P, 1993, DEVELOPMENT, P125
[3]   Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility [J].
Blume-Jensen, P ;
Jiang, GQ ;
Hyman, R ;
Lee, KF ;
O'Gorman, S ;
Hunter, T .
NATURE GENETICS, 2000, 24 (02) :157-162
[4]  
Brizzi MF, 1996, ONCOGENE, V13, P2067
[5]  
Broudy VC, 1999, BLOOD, V94, P1979
[6]   Cbl-b regulates the CD28 dependence of T-cell activation [J].
Chiang, YPJ ;
Kole, HK ;
Brown, K ;
Naramura, M ;
Fukuhara, S ;
Hu, RJ ;
Jang, IK ;
Gutkind, JS ;
Shevach, E ;
Gu, H .
NATURE, 2000, 403 (6766) :216-220
[7]  
Ettenberg S A, 1999, Mol Cell Biol Res Commun, V2, P111, DOI 10.1006/mcbr.1999.0157
[8]   cbl-b inhibits epidermal growth factor receptor signaling [J].
Ettenberg, SA ;
Keane, MM ;
Nau, MM ;
Frankel, M ;
Wang, LM ;
Pierce, JH ;
Lipkowitz, S .
ONCOGENE, 1999, 18 (10) :1855-1866
[9]   Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex [J].
Ettenberg, SA ;
Magnifico, A ;
Cuello, M ;
Nau, MM ;
Rubinstein, YR ;
Yarden, Y ;
Weissman, AM ;
Lipkowitz, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27677-27684
[10]   Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells [J].
Fang, D ;
Wang, HY ;
Fang, N ;
Altman, Y ;
Elly, C ;
Liu, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4872-4878